Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06496607 · ClinicalTrials.gov registry record · Phase 2

A Study to Evaluate Solriktug in Adult Participants With Asthma

A Phase 2 study of Asthma, sponsored by Uniquity One (UNI).

Recruiting
Registry status
Phase 2
Development phase
140
Enrollment target
20
Study locations

NCT06496607 is a Phase 2 study of Asthma that is actively recruiting participants, run by Uniquity One (UNI). The registered enrollment target is 140 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (91% lower). The trial reports 20 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06496607, a Phase 2 study of Asthma, is actively recruiting participants, sponsored by Uniquity One (UNI).

RECRUITING
Registry status
Phase 2
Development phase
140 participants
Enrollment target
20
Study locations

Study Summary

Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma.

Conditions Studied

Asthma

Interventions

  • BIOLOGICAL Placebo
  • BIOLOGICAL NSI-8226

Study Locations (20)

California

  • Warren W. Pleskow, M.D. - Encinitas
  • Beach Physicians Clinical Research Corp. - Huntington Beach
  • Biosolutions Clinical Research Center - La Mesa
  • Orso Health - Long Beach
  • Downtown LA Research Center - Los Angeles
  • Newport Native MD, Inc. - Newport Beach
  • Prospective Research Innovations Inc. - Rancho Cucamonga
  • Allergy & Asthma Medical Group and Research Center - San Diego
  • Allergy & Asthma Associates of Santa Clara Valley - San Jose
  • San Jose Clinical Trials - San Jose
  • North Bay Clinical Research - Santa Rosa
  • Providere Research - West Covina

Florida

  • Clinical Research of West Florida - Clearwater
  • JY Research Institute - Cutler Bay
  • Hillcrest Medical Research, LLC - DeLand
  • Clinical Site Partners LLC dba-Leesburg - Leesburg
  • Pharmax Research of South Florida - Miami

Alabama

  • Velocity Clinical Research - Mobile

Arizona

  • Phoenix Medical Group - Peoria

Colorado

  • Velocity Clinical Research - Denver - Englewood

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2024-07-26
Est. Completion 2026-09-30
Phase Phase 2

Sponsor

Uniquity One (UNI)

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06496607

The ClinicalTrials.gov registry entry for NCT06496607 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (91% lower). The listed sponsor is Uniquity One (UNI), which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06496607 reports 20 study locations spanning 5 distinct geographic areas - top geographies include California, Florida, Alabama.

Frequently Asked Questions

What is clinical trial NCT06496607 about?

NCT06496607 is a clinical study titled "A Study to Evaluate Solriktug in Adult Participants With Asthma". Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma.

What is the current status of trial NCT06496607?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 2024-07-26. Estimated completion is 2026-09-30.

What conditions does trial NCT06496607 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT06496607?

The interventions under investigation include: Placebo (BIOLOGICAL), NSI-8226 (BIOLOGICAL).

Who is sponsoring clinical trial NCT06496607?

This trial is sponsored by Uniquity One (UNI), which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06496607 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Asthma

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.